Joel Ackerman, Chief Executive Officer at CHAMPIONS ONCOLOGY, INC. (CSBR), bought 8,300 shares at $1.68 ($14K) on 2016-10-13, disclosed to the SEC on 2016-10-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.67 | 1,000 | $2K | 12.0% |
| 2 | $1.68 | 1,000 | $2K | 12.1% |
| 3 | $1.68 | 1,000 | $2K | 12.1% |
| 4 | $1.68 | 500 | $840 | 6.0% |
| 5 | $1.68 | 1,000 | $2K | 12.1% |
| 6 | $1.68 | 500 |
| $842 |
| 6.1% |
| 7 | $1.69 | 500 | $845 | 6.1% |
| 8 | $1.69 | 500 | $845 | 6.1% |
| 9 | $1.65 | 300 | $495 | 3.6% |
| 10 | $1.66 | 1,000 | $2K | 11.9% |
| 11 | $1.66 | 1,000 | $2K | 12.0% |
| Total | $1.67 avg | 8,300 | $14K | 100% |
| Filing → |
| DVA | SELL | 2021-08-06 | $9.9M | — | Filing → |
| CSBR | SELL | 2018-10-03 | $767K | — | Filing → |
| CSBR | BUY | 2016-10-20 | $5K | — | Filing → |